Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulation of N-acylethanolamine-hydrolysing acid amidase (NAAA) for disease treatment

Modulation of N-acylethanolamine-hydrolysing acid amidase (NAAA) for disease treatment

US Patent 10364242 · Granted Jul 30, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrazole derivatives for the treatment of cystic fibrosis2025
Pyrazole derivatives for the treatment of cystic fibrosis2025
Compounds and compositions for the treatment of cystic fibrosis2025
Compounds and compositions for the treatment of cystic fibrosis2025
Compounds and compositions for the treatment of cystic fibrosis2024
Compounds and compositions for the treatment of cystic fibrosis2024
Pyrazole derivatives for the treatment of cystic fibrosis2023
Pyrazole derivatives for the treatment of cystic fibrosis2023
Compounds and compositions for the treatment of cystic fibrosis2021
Compounds and compositions for the treatment of cystic fibrosis2021
Therapeutically active bicyclic-sulphonamides and pharmaceutical compositions2020
Therapeutically active bicyclic-sulphonamides and pharmaceutical compositions2020